AU2003257330A1 - New molecules for modulating drug resistance in fungus - Google Patents
New molecules for modulating drug resistance in fungusInfo
- Publication number
- AU2003257330A1 AU2003257330A1 AU2003257330A AU2003257330A AU2003257330A1 AU 2003257330 A1 AU2003257330 A1 AU 2003257330A1 AU 2003257330 A AU2003257330 A AU 2003257330A AU 2003257330 A AU2003257330 A AU 2003257330A AU 2003257330 A1 AU2003257330 A1 AU 2003257330A1
- Authority
- AU
- Australia
- Prior art keywords
- fungus
- drug resistance
- new molecules
- modulating drug
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40269302P | 2002-08-13 | 2002-08-13 | |
US60/402,693 | 2002-08-13 | ||
PCT/CA2003/001232 WO2004014349A1 (en) | 2002-08-13 | 2003-08-13 | New molecules for modulating drug resistance in fungus |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003257330A1 true AU2003257330A1 (en) | 2004-02-25 |
Family
ID=31715882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003257330A Abandoned AU2003257330A1 (en) | 2002-08-13 | 2003-08-13 | New molecules for modulating drug resistance in fungus |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003257330A1 (en) |
WO (1) | WO2004014349A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109266566B (en) * | 2018-10-12 | 2021-01-29 | 江南大学 | Method for adjusting osmotic pressure stress of Torulopsis glabrata |
-
2003
- 2003-08-13 WO PCT/CA2003/001232 patent/WO2004014349A1/en not_active Application Discontinuation
- 2003-08-13 AU AU2003257330A patent/AU2003257330A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004014349A1 (en) | 2004-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003266133A1 (en) | Materials and methods for drug delivery and uptake | |
AU2003301680A1 (en) | Platinum complexes | |
EP1587474A3 (en) | Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses | |
AU2003209594A1 (en) | Quinazoline compounds useful in therapy | |
EP2497513B8 (en) | Inhalator for powdery, in particular medical, substances | |
AU2003215209A1 (en) | Syringe | |
AU2003282356A1 (en) | Biological glue based on thrombin-conjugated nanoparticles | |
AU2003259457A1 (en) | Auto-destructible syringe | |
AU2003268672A1 (en) | Drug absorbability improving agents | |
AU2003243562A1 (en) | Polymeric label molecules | |
AU2003242396A1 (en) | Insulin resistance improving agents | |
EP1572168A3 (en) | Anti-infarction molecules | |
AU2003272260A1 (en) | Verifiable absorption drug delivery form based on cyclodextrins | |
AU2002358552A1 (en) | Nanostructure, in particular for analysing individual molecules | |
AU2003257330A1 (en) | New molecules for modulating drug resistance in fungus | |
AU2003291758A1 (en) | Waxy matrix dosage forms | |
AUPS198302A0 (en) | Improvements in bowsprits | |
AU2002953223A0 (en) | Novel therapeutic molecules and uses thereof | |
AU2003215767A1 (en) | Devices for use in medicine | |
WO2005058236A8 (en) | Cab molecules | |
AU2003276655A1 (en) | Pi - conjugated molecules | |
AU2003230760A1 (en) | Lipid-associated molecules | |
AU2002246447A1 (en) | Topical pathogenic-tissue-destroying liquid | |
AU2003905300A0 (en) | Therapeutic molecules | |
AU2003268985A1 (en) | Cannula |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |